William F. Benedict

Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis

S. Akinaga, J. Zhou, S. Yazumi, 2000, British Journal of Cancer.

p53 and RB expression predict progression in T1 bladder cancer.

C. Dinney, W. F. Benedict, J. Palmer, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.

Mark A. Stephenson, A. Marchevsky, P. Cagle, 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.

G E Moore, G. Moore, W. Benedict, 1991, Cancer research.

Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.

W. Benedict, J. Seigne, J. Li, 1996, Cancer research.

Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia.

E. Estey, W. Benedict, S. Kornblau, 1994, Blood.

Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.

S. Groshen, R. Cote, W. Benedict, 1998, Cancer research.

Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.

S. Hirohashi, W. Benedict, T. Sekiya, 1994, Cancer research.